Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-11-27
1992-07-21
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424 858, 424 88, 514 2, 514 21, A61K 3746, A61K 3702
Patent
active
051322870
ABSTRACT:
Human conglutinin, polyclonal, and monoclonal antibodies raised against human conglutinin, and their uses in therapy and diagnosis are described.
Human conglutinin was obtained from human plasma by affinity chromatography with anti-bovine conglutinin antibody, has a relative molecular weight of 330 and 40 K unreduced and 66 K reduced as measured by SDS-PAGE, shows calcium-dependent and sugar inhibitable binding to complement-reacted immune complexes and zymosan, and immunological cross-reaction with anti-bovine conglutinin antibody.
REFERENCES:
patent: 4239746 (1980-12-01), Bartos et al.
patent: 4342566 (1982-08-01), Theofilopoulos et al.
patent: 4427779 (1984-01-01), Reckel et al.
patent: 4503035 (1985-03-01), Pestka et al.
patent: 4548909 (1985-10-01), Parratt
Coombs et al., "The Serology of Conglutinin and its Relation to Disease", Blackwell Sci. Pub., Oxford, Adler & Sons Ltd., Bartholomew Press, Dorking, (1961), pp. 46-50, 128-137 and 184-194.
Lachmann et al., J. Immunol., 100:691-698 (1968).
Hirani et al., J. Immunol., 134(2):1105-1109 (1985).
Ingram, D. G., (1972), "Biological Aspects of Conglutinin and Immunoconglutinins", Biological Activities of Complement, Kager, Basel, pp. 215-228.
Ingram, D. G., Immunol., 2:322-333 (1959a).
Ingram, D. G., Immunol., 2:334-335 (1959b).
Casali et al., Clin. Exp. Immunol., 37:295-309 (1979).
Barta et al., J. Immunol., 105:350 (1970).
Jonas et al., Vet. Immunol. Immunopathol., 5:289 (1983/1984).
Kawasaki et al., J. Biochem., 98:1309-1320 (1985).
Leon et al., Science, 143:1327-1328 (1964).
Linscott et al., J. Immunol., 121(2):658-664 (1978).
Stankiewicz et al., Archivum Immunologiae Therapiae Experimentalis, 33:423-428 (1985).
Strang et al., Biochem. J., 234:381-389 (1986).
Tlaskalova et al., Folia Microbiol., (Prague), 13:450-458 (1968).
Brown et al., J. Immunol., 128(2):860-865 (1982).
Lachmann et al., "Conglutinin and Immunoconglutinins", pp. 202-214 in Biological Activities of Complement, ed., D. G. Ingram, (Karger, Basel, 1972).
Coombs et al., J. Hyg. Camb., 48:484-499 (1950).
Lachmann et al., Immunology, 18:157-169 (1970).
Durand et al., J. Imm. Methods, 73:57-66 (1984).
Mittal et al., Immunology, 25:237-240 (1973).
Eisenberg et al., J. Immunol., 118:1428-1434 (1977).
Jensenius et al., Biosci. Rep., 5(10-11):901-5 (1985).
Eggert, Biochem. Soc. Trans., 7:193-194 (1979).
Thiel et al., Scand. J. Immunol., 26:461-468 (1987).
Sage et al., J. Immunol., 90:347-357 (1963).
Lachmann et al., Immunochemistry, 1:37-41 (1964).
Eggert, Int. Arch. Allergy Appl. Immun., 61:192-202 (1980).
Eggert, Int. Arch. Allergy Appl. Immun., 61:203-212 (1980).
Eggert, Int. Arch. Allergy Appl. Immun., 62:34-45 (1980).
Lachmann, Adv. Immunol., 6:479-527 (1967).
Baatrup et al., Scand. J. Immunol., 26:355-361 (1987).
Lachmann, Immunology, 5:687-705 (1962).
Davis et al., Biochemistry, 23:2139-2144 (1984).
Dunker et al., J. Biol. Chem., 244:5047-5080 (1969).
Allison et al., PNAS USA, 75:3953-3956 (1978).
A copy of the European Search Report of the corresponding European Application No. 86 30 9595.
Ross et al., J. Immunol., 134:3307-3315 (1985).
Tamura, Biol. Abstracts, 71:59809 (1980).
Hautanen et al., Chem. Abstracts, 92:56616x (1980).
Samuel et al., Biol. Abstracts, 82:111882 (1986).
Gupta et al., Biol. Abstracts, 73:32120 (1981).
Novo Industri A/S
Schain Howard E.
LandOfFree
Methods of treating disorders which cause conglutinin deficiency does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating disorders which cause conglutinin deficiency, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating disorders which cause conglutinin deficiency will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-843319